8-K: Instil Bio 2026 Annual Meeting Voting Results

Instil Bio, Inc. stockholders re-elected Class II directors and ratified the appointment of RSM US LLP as the company's independent auditor for 2026.

Summary

• The 2026 Annual Meeting of Stockholders was held on June 11, 2026.
• Approximately 84.9% of outstanding shares were represented at the meeting.
• Stockholders elected George Matcham and Neil Gibson as Class II directors.
• Stockholders ratified the selection of RSM US LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine corporate governance filing with no material impact on the company's financial trajectory.

Positives

• High voter turnout with 84.9% of outstanding shares represented at the meeting.
• Strong shareholder support for the ratification of the independent auditor, with 5,750,869 votes for and only 6,911 against.

Negatives

• Significant number of withheld votes for director nominees (742,925 for Matcham and 822,138 for Gibson).

Risks

• None disclosed in this filing.

Future Outlook

The filing does not contain forward-looking financial guidance.

Industry Context

StockSavvy.ai notes that the ratification of auditors and election of directors are standard procedural items for biotech firms, reflecting stable corporate governance despite the volatile nature of the sector.

Comparison to Industry Standards

• The voting turnout of 84.9% is consistent with typical participation levels for small-cap biotechnology companies.
• The ratification of the audit firm is standard practice and aligns with SEC and Nasdaq listing requirements.

Corporate Governance

Stakeholder Impact

• Shareholders have confirmed the board composition and audit oversight for the upcoming fiscal year.

Next Steps

• Directors will serve until the 2029 Annual Meeting of Stockholders.
• RSM US LLP will conduct the audit for the fiscal year ending December 31, 2026.

Key Dates

Keywords

Instil Bio, Annual Meeting, Proxy Voting, Corporate Governance, TIL, SEC Filing